These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 485115)

  • 1. [Prodigiozan aerosols in the treatment of nonspecific respiratory organ diseases in children].
    Pedanova VM; Smorchkov AP; Furer NM; Iurina TM; Savitskaia KL
    Antibiotiki; 1979 Aug; 24(8):632-5. PubMed ID: 485115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Interferonogenic properties of prodigiozan and its effectiveness in treating acute respiratory diseases in children].
    Povolotskiĭ IaL; Andrushchuk AA; Korzhenevskiĭ AF; Krivokhatskaia LD
    Antibiotiki; 1980 Jul; 25(7):531-4. PubMed ID: 6157358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prodigiozan in the complex treatment of respiratory tract sarcoidosis].
    Daurov BI; Poletaev SD; Stefani DV
    Klin Med (Mosk); 1982 Sep; 60(9):90-3. PubMed ID: 6983627
    [No Abstract]   [Full Text] [Related]  

  • 4. [Comparative results of lysozyme and prodigiozan aerosol treatment of complicated forms of pneumoconiosis].
    Mursalimov ZM; Mazhinskaia LA; Agal'tseva VI
    Gig Tr Prof Zabol; 1980 Dec; (12):55-7. PubMed ID: 6449419
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effect of the inhalation of prodigiozan on the incidence of inflammatory diseases of the upper respiratory tract].
    Kuznetsov VS; Abdulkhamidov KhB
    Vestn Otorinolaringol; 1986; (4):49-51. PubMed ID: 3750619
    [No Abstract]   [Full Text] [Related]  

  • 6. [Use of prodigiozan for preventing acute respiratory viral diseases in a children's collective].
    Turgunbaev OT; Martynova LG
    Antibiotiki; 1978 Feb; 23(2):183-5. PubMed ID: 204248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Lysozyme aerosols in the overall treatment of children with bronchopulmonary diseases].
    Matveeva LA; Zemliakova ZM
    Vopr Kurortol Fizioter Lech Fiz Kult; 1980; (5):49-50. PubMed ID: 7434668
    [No Abstract]   [Full Text] [Related]  

  • 8. [Use of prodigiozan and lysozyme in ENT organ diseases].
    Brofman AV
    Zh Ushn Nos Gorl Bolezn; 1980; 1():46-51. PubMed ID: 7361524
    [No Abstract]   [Full Text] [Related]  

  • 9. [Use of prodigiozan in the combined therapy of infectious diseases (a review of the literature)].
    Frolov VM; Rychnev VE
    Vrach Delo; 1986 Feb; (2):111-4. PubMed ID: 3518241
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effect of gentamycin in combination with prodigiozan on the immunological reactivity of the body].
    Shcherbakova EG; Rastunova GA; Vvedenskaia OI; Zhuravleva TP; Medvedeva MM
    Antibiotiki; 1979 Sep; 24(9):679-84. PubMed ID: 573585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effectiveness of levamisole, prodigiozan and diucifon in the treatment of acute pneumonia].
    Sil'vestrov VP; Karaulov AV; Likov VF
    Ter Arkh; 1983; 55(12):56-61. PubMed ID: 6665720
    [No Abstract]   [Full Text] [Related]  

  • 12. [Prodigiozan electrophoresis in the combined treatment of gonorrhea in women].
    Kuntsevich LD; Strugatskaia GS; Borshchevskaia RP; Semikletova AIu
    Vestn Dermatol Venerol; 1982 Jun; (6):62-5. PubMed ID: 7124113
    [No Abstract]   [Full Text] [Related]  

  • 13. [Immediate and late results of complex antibacterial therapy of pulmonary tuberculosis in children and adolescents in combination with tuberculin PPD-L or prodigiozan].
    Tsymbaliuk GF
    Probl Tuberk; 1982 Oct; (10):46-50. PubMed ID: 7178103
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical evaluation of the therapeutic effectiveness of a new drug with anti-inflammatory-balsamic action, guacetisal, in respiratory tract diseases].
    Bartolucci L; Canini F; Fioroni E; Pinchi G; Carosi M
    Minerva Med; 1981 Feb; 72(7):325-32. PubMed ID: 7017481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The use of prodigiozan for the nonspecific prevention of influenza and ARD among frequently ill schoolchildren].
    Ignat'eva GS; Gagarinova VM; Ivanova AM; Rodina MA; Protasova SF; Markelova NF; Katorgina LG; Perova NS
    Pediatriia; 1990; (9):67-70. PubMed ID: 2147993
    [No Abstract]   [Full Text] [Related]  

  • 16. [Use of prodigiozan in the overall treatment of pulmonary tuberculosis in children and adolescents].
    Kshanovskiĭ SA; Rushchak VA; Tsymbaliuk GF; Kostromina VP; Medvedeva MM
    Probl Tuberk; 1980 Jan; (1):33-6. PubMed ID: 6966060
    [No Abstract]   [Full Text] [Related]  

  • 17. [Penicillin concentration in the blood and sputum and its urinary excretion in patients with chronic inflammatory diseases of the respiratory organs following its endobronchial administration through a catheter and in the form of an aerosol].
    Sazonov VF
    Antibiotiki; 1974 Jul; 19(7):648-51. PubMed ID: 4463899
    [No Abstract]   [Full Text] [Related]  

  • 18. [Aerosol therapy in children. (On 1800 cases)].
    Nanulescu M; Mustăţea N; Kraft A
    Pediatria (Bucur); 1973; 22(2):173-80. PubMed ID: 4720588
    [No Abstract]   [Full Text] [Related]  

  • 19. [Value of determining the spectrum of blood serum fatty acids in evaluating increasing the effectiveness of antibiotic therapy of dysentery in children with prodigiozan and ephedrine].
    Vereshchagin IA; Zhuravleva OD
    Antibiot Khimioter; 1989 Mar; 34(3):218-23. PubMed ID: 2502081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of comprehensive antibacterial therapy in combination with prodigiozan on energy metabolic indices in children and adolescents with pulmonary tuberculosis].
    Kshanovs'kyĭ SA; Rushchak VA; Maliuk VI; Vel'tman RV; Polner RA
    Pediatr Akus Ginekol; 1979; (3):16-8. PubMed ID: 379787
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.